The clinical and diagnostic role of microRNAs in ovarian carcinoma

Gynecologic Oncology

Volumn 133, Issue 3, 2014, Pages 640-646

  Davidson, Ben ^a,b   Tropé, Claes G ^a,b   Reich, Reuven ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Chemotherapy; Diagnosis; MicroRNA; Ovarian carcinoma; Prognosis

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 126; MICRORNA 132; MICRORNA 141; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 182; MICRORNA 192; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 205; MICRORNA 210; MICRORNA 214; MICRORNA 22; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 26A; MICRORNA 29A; MICRORNA 29B; MICRORNA 31; MICRORNA 9; PACLITAXEL;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PROGNOSIS; DIAGNOSIS; DRUG RESPONSE; GENE TARGETING; HUMAN; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

CHEMOTHERAPY; DIAGNOSIS; MICRORNA; OVARIAN CARCINOMA; PROGNOSIS;

ANTINEOPLASTIC AGENTS; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 84901655594     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.03.575     Document Type: Review

References (86)

1. R.C. Lee, R.L. Feinbaum, and V. Ambros The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 75 1993 843 854
2. B.R. Cullen Transcription and processing of human microRNA precursors Mol Cell 16 2004 861 865
3. A.J. Pratt, and I.J. MacRae The RNA-induced silencing complex: a versatile gene-silencing machine J Biol Chem 284 2009 17897 17901
4. A. Grimson, K.K. Farh, W.K. Johnston, P. Garrett-Engele, L.P. Lim, and D.P. Bartel MicroRNA targeting specificity in mammals: determinants beyond seed pairing Mol Cell 27 2007 91 105
5. S. Gu, L. Jin, F. Zhang, P. Sarnow, and M.A. Kay Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs Nat Struct Mol Biol 16 2009 144 150
6. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, D.P. Bartel, and C.B. Burge Prediction of mammalian microRNA targets Cell 115 2003 787 798
7. G.A. Calin, C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, and E. Noch et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proc Natl Acad Sci U S A 99 2002 15524 15529
8. W. Zhang, J.E. Dahlberg, and W. Tam MicroRNAs in tumorigenesis: a primer Am J Pathol 171 2007 728 738
9. J.L. Bearfoot, D.Y. Choong, K.L. Gorringe, and I.G. Campbell Genetic analysis of cancer-implicated MicroRNA in ovarian cancer Clin Cancer Res 14 2008 7246 7250
10. G.L. Ryland, J.L. Bearfoot, M.A. Doyle, S.E. Boyle, D.Y. Choong, and S.M. Rowley et al. MicroRNA genes and their target 3′-untranslated regions are infrequently somatically mutated in ovarian cancers PLoS One 7 2012 e3580
11. J. Permuth-Wey, Z. Chen, Y.Y. Tsai, H.Y. Lin, Y.A. Chen, J. Barnholtz-Sloan Ovarian Cancer Association Consortium (OCAC) MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium Cancer Epidemiol Biomarkers Prev 20 2011 1793 1797
12. K.E. Resnick, H. Alder, J.P. Hagan, D.L. Richardson, C.M. Croce, and D.E. Cohn The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform Gynecol Oncol 112 2009 55 59
13. S.F. Häusler, A. Keller, P.A. Chandran, K. Ziegler, K. Zipp, and S. Heuer et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening Br J Cancer 103 2010 693 700
14. H. Zheng, L. Zhang, Y. Zhao, D. Yang, F. Song, and Y. Wen et al. Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer PLoS One 8 2013 e77853
15. C.W. Kan, M.A. Hahn, G.B. Gard, J. Maidens, J.Y. Huh, and D.J. Marsh et al. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer BMC Cancer 12 2012 627
16. Y.W. Chung, H.S. Bae, J.Y. Song, J.K. Lee, N.W. Lee, and T. Kim et al. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patient Int J Gynecol Cancer 23 2013 673 679
17. D.D. Taylor, and C. Gercel-Taylor MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol Oncol 110 2008 13 21
18. M.V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, and P. Casalini et al. MicroRNA signatures in human ovarian cancer Cancer Res 67 2007 8699 8707
19. S.K. Wyman, R.K. Parkin, P.S. Mitchell, B.R. Fritz, K. O'Briant, and A.K. Godwin et al. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries PLoS One 4 2009 e5311
20. S.W. Shahab, L.V. Matyunina, R. Mezencev, L.D. Walker, N.J. Bowen, and B.B. Benigno et al. Evidence for the complexity of microRNA-mediated regulation in ovarian cancer: a systems approach PLoS One 6 2011 e22508
21. E. Calura, R. Fruscio, L. Paracchini, E. Bignotti, A. Ravaggi, and P. Martini et al. MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities Clin Cancer Res 19 2013 4114 4123
22. R. Bhattacharya, M. Nicoloso, R. Arvizo, E. Wang, A. Cortez, and S. Rossi et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer Cancer Res 69 2009 9090 9095
23. C. Polytarchou, D. Iliopoulos, M. Hatziapostolou, F. Kottakis, I. Maroulakou, and K. Struhl et al. Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation Cancer Res 71 2011 4720 4731
24. W. Jia, J.O. Eneh, S. Ratnaparkhe, M.K. Altman, and M.M. Murph MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9 Mol Cancer Res 9 2011 1732 1745
25. D.C. Corney, C.I. Hwang, A. Matoso, M. Vogt, A. Flesken-Nikitin, and A.K. Godwin et al. Frequent downregulation of miR-34 family in human ovarian cancers Clin Cancer Res 16 2010 1119 1128
26. Y. Guan, H. Yao, Z. Zheng, G. Qiu, and K. Sun MiR-125b targets BCL3 and suppresses ovarian cancer proliferation Int J Cancer 128 2011 2274 2283
27. Y.M. Yeh, C.M. Chuang, K.C. Chao, and L.H. Wang MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α Int J Cancer 133 2013 867 878
28. A. Parikh, C. Lee, J. Peronne, S. Marchini, A. Baccarini, and V. Kolev et al. microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition Nat Commun 5 2014 2977
29. Z. Liu, J. Liu, M.F. Segura, C. Shao, P. Lee, and Y. Gong et al. MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma J Pathol 228 2012 204 215
30. A. Bendoraite, E.C. Knouf, K.S. Garg, R.K. Parkin, E.M. Kroh, and K.C. O'Briant et al. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition Gynecol Oncol 116 2010 117 125
31. L.K. Mullany, H.Y. Fan, Z. Liu, L.D. White, A. Marshall, and P. Gunaratne et al. Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo Oncogene 30 2011 3522 3536
32. R.J. Flavin, P.C. Smyth, A. Laios, S.A. O'Toole, C. Barrett, and S.P. Finn et al. Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma Mod Pathol 22 2009 197 205
33. E.C. Knouf, K. Garg, J.D. Arroyo, Y. Correa, D. Sarkar, and R.K. Parkin et al. An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription Nucleic Acids Res 40 2012 499 510
34. N. Dahiya, C.A. Sherman-Baust, T.L. Wang, B. Davidson, Shih IeM, and Y. Zhang et al. MicroRNA expression and identification of putative miRNA targets in ovarian cancer PLoS One 3 2008 e2436
35. O. Vaksman, H.T. Stavnes, J. Kaern, C.G. Tropé, B. Davidson, and R. Reich miRNA profiling along tumour progression in ovarian carcinoma J Cell Mol Med 15 2011 1593 1602
36. J. Wu, Z. Liu, C. Shao, Y. Gong, E. Hernando, and P. Lee et al. HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes Cancer Res 71 2011 349 359
37. K.D. Cowden Dahl, R. Dahl, J.N. Kruichak, and L.G. Hudson The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells Neoplasia 11 2009 1208 1215
38. A.K. Mitra, M. Zillhardt, Y. Hua, P. Tiwari, A.E. Murmann, and M.E. Peter et al. MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer Cancer Discov 2 2012 1100 1108
39. C. Sun, N. Li, Z. Yang, B. Zhou, Y. He, and D. Weng et al. miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition J Natl Cancer Inst 105 2013 1750 1758
40. T. Mitamura, H. Watari, L. Wang, H. Kanno, M.K. Hassan, and M. Miyazaki et al. Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET Oncogenesis 2 2013 e40
41. X. Fu, J. Tian, L. Zhang, Y. Chen, and Q. Hao Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells FEBS Lett 586 2012 1279 1286
42. J.H. Huh, T.H. Kim, K. Kim, J.A. Song, Y.J. Jung, and J.Y. Jeong et al. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer Br J Cancer 109 2013 452 461
43. M.T. van Jaarsveld, J. Helleman, A.W. Boersma, P.F. van Kuijk, W.F. van Ijcken, and E. Despierre et al. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells Oncogene 32 2013 4284 4293
44. Y.Q. Wang, R.D. Guo, R.M. Guo, W. Sheng, and L.R. Yin MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas J Cell Biochem 114 2013 1464 1473
45. W. Cheng, T. Liu, X. Wan, Y. Gao, and H. Wang MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells FEBS J 279 2012 2047 2059
46. D.M. Cittelly, I. Dimitrova, E.N. Howe, D.R. Cochrane, A. Jean, and N.S. Spoelstra et al. Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel Mol Cancer Ther 11 2012 2556 2565
47. H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, and J. Wang et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2008 425 433
48. G. Ye, G. Fu, S. Cui, S. Zhao, S. Bernaudo, and Y. Bai et al. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance J Cell Sci 124 2011 359 368
49. F. Furlong, P. Fitzpatrick, S. O'Toole, S. Phelan, B. McGrogan, and A. Maguire et al. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer J Pathol 226 2012 746 755
50. A. Vecchione, B. Belletti, F. Lovat, S. Volinia, G. Chiappetta, and S. Giglio et al. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis Proc Natl Acad Sci U S A 110 2013 9845 9850
51. B. Boyerinas, S.M. Park, A.E. Murmann, K. Gwin, A.G. Montag, and M. Zillhardt et al. Let-7 modulates acquired resistance of ovarian cancer to taxanes via IMP-1-mediated stabilization of multidrug resistance 1 Int J Cancer 130 2012 1787 1797
52. A. Laios, S. O'Toole, R. Flavin, C. Martin, L. Kelly, and M. Ring et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer Mol Cancer 7 2008 35
53. S. Vang, H.T. Wu, A. Fischer, D.H. Miller, S. MacLaughlan, and E. Douglass et al. Identification of ovarian cancer metastatic miRNAs PLoS One 8 2013 e58226
54. O. Vaksman, T.E. Hetland, C.G. Tropé, R. Reich, and B. Davidson Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma Hum Pathol 43 2012 2062 2069
55. T.H. Kim, Y.K. Kim, Y. Kwon, J.H. Heo, H. Kang, and G. Kim et al. Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours Histopathology 57 2010 734 743
56. R. Flavin, P. Smyth, C. Barrett, S. Russell, H. Wen, and J. Wei et al. miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma Int J Gynecol Cancer 19 2009 641 647
57. N. Li, S. Kaur, J. Greshock, H. Lassus, X. Zhong, and Y. Wang et al. A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer Cancer Res 72 2012 154 164
58. C.J. Creighton, A. Hernandez-Herrera, A. Jacobsen, D.A. Levine, P. Mankoo, N. Schultz Cancer Genome Atlas Research Network Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma PLoS One 7 2012 e34546
59. D. Reimer, M. Hubalek, H. Kiefel, S. Riedle, S. Skvortsov, and M. Erdel et al. Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer Oncogene 30 2011 4038 4049
60. D.X. Peng, M. Luo, L.W. Qiu, Y.L. He, and X.F. Wang Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer Oncol Rep 27 2012 1238 1244
61. C. Ivan, W. Hu, J. Bottsford-Miller, B. Zand, H.J. Dalton, and T. Liu et al. Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer Gynecol Oncol 128 2013 506 511
62. X. Zhou, F. Zhao, Z.N. Wang, Y.X. Song, H. Chang, and Y. Chiang et al. Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation Oncol Rep 27 2012 447 454
63. B.D. McMillen, M.M. Aponte, Z. Liu, I.B. Helenowski, D.M. Scholtens, and B.M. Buttin et al. Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma Mod Pathol 25 2012 1644 1653
64. A. Chao, C.Y. Lin, Y.S. Lee, C.L. Tsai, P.C. Wei, and S. Hsueh et al. Regulation of ovarian cancer progression by microRNA-187 through targeting disabled homolog-2 Oncogene 31 2012 764 775
65. X. Hu, D.M. Macdonald, P.C. Huettner, Z. Feng, I.M. El Naqa, and J.K. Schwarz et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer Gynecol Oncol 114 2009 457 464
66. S. Marchini, D. Cavalieri, R. Fruscio, E. Calura, D. Garavaglia, and I.F. Nerini et al. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections Lancet Oncol 12 2011 273 285
67. S. Wang, X. Zhao, J. Wang, Y. Wen, L. Zhang, and D. Wang et al. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer Med Oncol 30 2013 681
68. F. Hong, Y. Li, Y. Xu, and L. Zhu Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer J Int Med Res 41 2013 64 71
69. K. Wurz, R.L. Garcia, B.A. Goff, P.S. Mitchell, J.H. Lee, and M. Tewari et al. MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: relationship to CDKN1B, CDKNIC and overall survival Genes Chromosomes Cancer 49 2010 577 584
70. K.K. Shih, L.X. Qin, E.J. Tanner, Q. Zhou, M. Bisogna, and F. Dao et al. A microRNA survival signature (MiSS) for advanced ovarian cancer Gynecol Oncol 121 2011 444 450
71. Z. Tang, G.S. Ow, J.P. Thiery, A.V. Ivshina, and V.A. Kuznetsov Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma Int J Cancer Jul. 3 2013 10.1002/ijc.28371 [Epub ahead of print]
72. H. Lee, C.S. Park, G. Deftereos, J. Morihara, J.E. Stern, and S.E. Hawes et al. MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features World J Surg Oncol 10 2012 174
73. R.J. Flavin, P.C. Smyth, S.P. Finn, A. Laios, S.A. O'Toole, and C. Barrett et al. Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients Mod Pathol 21 2008 676 684
74. A. Faggad, J. Budczies, O. Tchernitsa, S. Darb-Esfahani, J. Sehouli, and B.M. Müller et al. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression J Pathol 220 2010 382 391
75. W.M. Merritt, Y.G. Lin, L.Y. Han, A.A. Kamat, W.A. Spannuth, and R. Schmandt et al. Dicer, Drosha, and outcomes in patients with ovarian cancer N Engl J Med 359 2008 2641 2650
76. E.J. Nam, H. Yoon, S.W. Kim, H. Kim, Y.T. Kim, and J.H. Kim et al. MicroRNA expression profiles in serous ovarian carcinoma Clin Cancer Res 14 2008 2690 2695
77. C.H. Lee, S. Subramanian, A.H. Beck, I. Espinosa, J. Senz, and S.X. Zhu et al. MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary PLoS One 4 2009 e7314
78. B. Mateescu, L. Batista, M. Cardon, T. Gruosso, Y. de Feraudy, and O. Mariani et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response Nat Med 17 2011 1627 1635
79. S. Bentink, B. Haibe-Kains, T. Risch, J.B. Fan, M.S. Hirsch, and K. Holton et al. Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer PLoS One 7 2012 e30269
80. K.R. Delfino, and S.L. Rodriguez-Zas Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence PLoS One 8 2013 e58608
81. X. Yu, X. Zhang, T. Bi, Y. Ding, J. Zhao, and C. Wang et al. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma Tumour Biol 34 2013 3501 3508
82. L. Zhang, S. Volinia, T. Bonome, G.A. Calin, J. Greshock, and N. Yang et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer Proc Natl Acad Sci U S A 105 2008 7004 7009
83. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
84. D. Yang, Y. Sun, L. Hu, H. Zheng, P. Ji, and C.V. Pecot et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer Cancer Cell 23 2013 186 199
85. W. Zhang, Y. Liu, N. Sun, D. Wang, J. Boyd-Kirkup, and X. Dou et al. Integrating genomic, epigenomic, and transcriptomic features reveals modular signatures underlying poor prognosis in ovarian cancer Cell Rep 4 2013 542 553
86. M. Nishimura, E.J. Jung, M.Y. Shah, C. Lu, R. Spizzo, and M. Shimizu et al. Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment Cancer Discov 3 2013 1302 1315